Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

The International Food Information Council (IFIC) has published a new survey examining Americans’ attitudes and perceptions toward obesity medications. The IFIC Spotlight Survey: Americans’ ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Weight loss injections are administered with a needle under the skin. Some injectable prescription medications, like liraglutide (Saxenda®) and tirzepatide (Zepbound® and Mounjaro®), support ...